| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Biopsy helpful in diagnosing a liver mass in pregnancy: focal nodular hyperplasia
|
Yaqub, Sheraz
|
|
|
402 |
10403 |
p. e10
|
article
|
| 2 |
CagriSema and the link between obesity and type 2 diabetes
|
Apovian, Caroline M
|
|
|
402 |
10403 |
p. 671-673
|
article
|
| 3 |
China's crackdown on health-care corruption
|
Yuan, Shawn
|
|
|
402 |
10403 |
p. 681-682
|
article
|
| 4 |
Chinyere Ezeaka: reforming newborn health care in Nigeria
|
Davies, Rachael
|
|
|
402 |
10403 |
p. 683
|
article
|
| 5 |
Concerns about new proposals for haemochromatosis screening
|
McClements, Neil
|
|
|
402 |
10403 |
p. 690-691
|
article
|
| 6 |
Concerns about new proposals for haemochromatosis screening
|
Fish, Louise
|
|
|
402 |
10403 |
p. 691-692
|
article
|
| 7 |
Concerns about new proposals for haemochromatosis screening – Authors' reply
|
Adams, Paul C
|
|
|
402 |
10403 |
p. 692
|
article
|
| 8 |
Department of Error
|
|
|
|
402 |
10403 |
p. 692
|
article
|
| 9 |
Department of Error
|
|
|
|
402 |
10403 |
p. 692
|
article
|
| 10 |
Department of Error
|
|
|
|
402 |
10403 |
p. 692
|
article
|
| 11 |
Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial
|
Frias, Juan P
|
|
|
402 |
10403 |
p. 720-730
|
article
|
| 12 |
Efficacy and safety of once-daily oral semaglutide 25 mg and 50 mg compared with 14 mg in adults with type 2 diabetes (PIONEER PLUS): a multicentre, randomised, phase 3b trial
|
Aroda, Vanita R
|
|
|
402 |
10403 |
p. 693-704
|
article
|
| 13 |
Improving health system performance in Mexico
|
Unger-Saldaña, Karla
|
|
|
402 |
10403 |
p. 674-676
|
article
|
| 14 |
Israel's judicial overhaul: a threat to the Health in All Policies approach
|
Kamin-Friedman, Shelly
|
|
|
402 |
10403 |
p. 689-690
|
article
|
| 15 |
Omicron neutralisation: RBD-dimer booster versus BF.7 and BA.5.2 breakthrough infection
|
Dai, Lianpan
|
|
|
402 |
10403 |
p. 687-689
|
article
|
| 16 |
Oral semaglutide: an OASIS from injectables
|
Manjoo, Priya
|
|
|
402 |
10403 |
p. 670-671
|
article
|
| 17 |
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
|
Knop, Filip K
|
|
|
402 |
10403 |
p. 705-719
|
article
|
| 18 |
Perinatal depression: a neglected aspect of maternal health
|
The Lancet,
|
|
|
402 |
10403 |
p. 667
|
article
|
| 19 |
Setbacks in the quest for universal health coverage in Mexico: polarised politics, policy upheaval, and pandemic disruption
|
Knaul, Felicia Marie
|
|
|
402 |
10403 |
p. 731-746
|
article
|
| 20 |
Strengthening Africa's voice on boards of global health initiatives
|
e Silva, Magda Robalo Correia
|
|
|
402 |
10403 |
p. 677-678
|
article
|
| 21 |
Syria after the earthquake
|
Skyle, Daniel
|
|
|
402 |
10403 |
p. 679-680
|
article
|
| 22 |
The pursuit of optimal semaglutide dosing in type 2 diabetes continues
|
Sherrill, Christina H
|
|
|
402 |
10403 |
p. 668-669
|
article
|
| 23 |
What do you see when you look at me? Narratives of visible disease
|
Farooki, Roopa
|
|
|
402 |
10403 |
p. 684-685
|
article
|
| 24 |
William Sidney Robinson
|
Watts, Geoff
|
|
|
402 |
10403 |
p. 686
|
article
|
Journal description